Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alpha Teknova, Inc.

5.48
-0.3300-5.68%
Post-market: 5.480.00000.00%16:04 EDT
Volume:193.99K
Turnover:1.09M
Market Cap:292.86M
PE:-11.74
High:5.84
Open:5.81
Low:5.46
Close:5.81
Loading ...

Alpha Teknova (TKNO) Receives a Buy from Craig-Hallum

TIPRANKS
·
09 May

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alpha Teknova (TKNO), Definitive Healthcare Corp (DH) and Wave Life Sciences (WVE)

TIPRANKS
·
09 May

Alpha Teknova (TKNO) Gets a Buy from William Blair

TIPRANKS
·
09 May

Alpha Teknova Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Alpha Teknova Q1 EPS $(0.09) Beats $(0.12) Estimate, Sales $9.79M Beat $9.37M Estimate

Benzinga
·
09 May

BRIEF-Alpha Teknova Q1 EPS USD -0.09

Reuters
·
09 May

Alpha Teknova Q1 EPS USD -0.09

THOMSON REUTERS
·
09 May

Alpha Teknova Q1 Revenue USD 9.795 Million

THOMSON REUTERS
·
09 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 May

Alpha Teknova Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
07 May

Alpha Teknova (TKNO) Traded Lower on Increased Uncertainty

Insider Monkey
·
30 Apr

Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

GlobeNewswire
·
25 Apr

Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies

GlobeNewswire
·
19 Mar

BTIG Reaffirms Their Hold Rating on Alpha Teknova (TKNO)

TIPRANKS
·
18 Mar

Alpha Teknova, Pluristyx Partner to Produce, Distribute PluriFreeze for Cell Therapies

MT Newswires Live
·
12 Mar

Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies

GlobeNewswire
·
12 Mar

Alpha Teknova Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
08 Mar

Alpha Teknova’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
06 Mar

Positive Outlook for Alpha Teknova: Strong Financial Performance and Growth Potential

TIPRANKS
·
05 Mar

Alpha Teknova: Strong Revenue Growth and Strategic Positioning Justify Buy Rating

TIPRANKS
·
05 Mar